FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
 OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Sides David William		 2. Issuer Name and Ticker or Trading Symbol

NEXTGEN HEALTHCARE, INC. [ NXGN ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
President and CEO
(Last)          (First)          (Middle)

3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700		 3. Date of Earliest Transaction (MM/DD/YYYY)

9/22/2022
(Street)

ATLANTA, GA 30305
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
 6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 9/22/2022  M  24334 A (1)673715 D  
Common Stock 9/22/2022  F(2)  11256 D$17.02 662459 D  
Common Stock 9/22/2022  F(3)  72627 D$17.02 589832 D  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)		2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)		8. Price of Derivative Security
(Instr. 5)		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Performance Stock Units  (1)9/22/2022  M     24334   (4) (4)Common Stock 24334 $0.00 425666 D  
Explanation of Responses:
(1) Performance stock units convert to shares of NXGN common stock on a one-for-one basis once fully vested.
(2) Represents shares withheld to satisfy tax withholding obligations on the vesting of performance stock units.
(3) Represents shares withheld to satisfy tax withholding obligations on the vesting of restricted stock.
(4) The reporting person was granted performance stock units that vest upon both the attainment of four separate pre-determined stock price milestones and continued service over a period of three years commencing September 22, 2021. 73,000 of these performance stock units were tied to a stock price milestone of $19.38, which was met in April 2022. As of September 22, 2022, 1/3 of the performance stock units tied to the $19.38 stock price milestone are fully vested. The remaining 48,666 performance stock units tied to the $19.38 stock price milestone will vest in equal installments on September 22, 2023 and September 22, 2024.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Sides David William
3525 PIEDMONT RD., NE
BUILDING 6, SUITE 700
ATLANTA, GA 30305		X
President and CEO
Signatures
/s/ Jeffrey D. Linton, Attorney-in-Fact for David Sides9/26/2022
**Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
NextGen Healthcare (NASDAQ:NXGN)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more NextGen Healthcare Charts.
NextGen Healthcare (NASDAQ:NXGN)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more NextGen Healthcare Charts.